Corporate
8 Aug 2025
Intas Pharmaceuticals, Accord BioPharma acquires UDENYCA
UDENYCA, a biosimilar to Neulasta (pegfilgrastim), significantly expands Intas and Accord's FDA-approved biosimilar portfolio Intas Pharmaceuticals, in collaboration with its global…
